Request a document copy: Efficacy/safety Of Ocrelizumab In Relapsing-remitting MS Patients With Suboptimal Response To Prior Disease-modifying Therapies (1-yr Interim Results)

all files (of this document) in restricted access
the file(s) you requested
Cancel